Bicalutamide 80 mg combined with a luteinizing...

Prostate Cancer and Prostatic Diseases 2007 / 5 Vol. 10; Iss. 2

Bicalutamide 80 mg combined with a luteinizing hormone-releasing hormone agonist (LHRH-A) versus LHRH-A monotherapy in advanced prostate cancer: findings from a phase III randomized, double-blind, multicenter trial in Japanese patients

Usami, M, Akaza, H, Arai, Y, Hirano, Y, Kagawa, S, Kanetake, H, Naito, S, Sumiyoshi, Y, Takimoto, Y, Terai, A, Yoshida, H, Ohashi, Y
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Language:
english
Journal:
Prostate Cancer and Prostatic Diseases
DOI:
10.1038/sj.pcan.4500934
Date:
May, 2007
File:
PDF, 117 KB
english, 2007
Conversion to is in progress
Conversion to is failed